GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Milestone Scientific Inc (AMEX:MLSS) » Definitions » Long-Term Debt & Capital Lease Obligation

Milestone Scientific (Milestone Scientific) Long-Term Debt & Capital Lease Obligation : $0.28 Mil (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Milestone Scientific Long-Term Debt & Capital Lease Obligation?

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Milestone Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.28 Mil.

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligation divides by its Total Assets. Milestone Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.28 Mil. Milestone Scientific's Total Assets for the quarter that ended in Dec. 2023 was $11.37 Mil. Milestone Scientific's LT-Debt-to-Total-Asset for the quarter that ended in Dec. 2023 was 0.03.

Milestone Scientific's LT-Debt-to-Total-Asset declined from Dec. 2022 (0.03) to Dec. 2023 (0.03). It may suggest that Milestone Scientific is progressively becoming less dependent on debt to grow their business.


Milestone Scientific Long-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Milestone Scientific's Long-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Milestone Scientific Long-Term Debt & Capital Lease Obligation Chart

Milestone Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.59 0.50 0.40 0.28

Milestone Scientific Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Long-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.37 0.34 0.31 0.28

Milestone Scientific Long-Term Debt & Capital Lease Obligation Calculation

Long-Term Debt is the debt due more than 12 months in the future. The debt can be owed to banks or bondholders. Some companies issue bonds to investors and pay interest on the bonds.

Long-Term Capital Lease Obligation represents the total liability for long-term leases lasting over one year. It's amount equal to the present value (the principal) at the beginning of the lease term less lease payments during the lease term.

The interest paid on companies' debt is reflected in the income statement as interest expense. If a company has too much debt and it cannot serve the interest payment on the debt or repay the matured debt, the company risks bankruptcy. Peter Lynch famously said: A company that does not have debt cannot go bankrupt.

A company's long term debt may have different dates of maturity and interest rates, depending on the terms.

Usually a company issues long term debt to pay for its capital expenditures. Borrowing allows the company to do things that otherwise cannot be done with only the capital it has. But debt can be risky.


Milestone Scientific  (AMEX:MLSS) Long-Term Debt & Capital Lease Obligation Explanation

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Milestone Scientific's LT-Debt-to-Total-Asset ratio for the quarter that ended in Dec. 2023 is calculated as:

LT-Debt-to-Total-Asset (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=0.282/11.372
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Buffett says that durable competitive advantages carry little to no long-term debt because the company is so profitable that even expansions or acquisitions are self financed.

We are interested in long term debt load for the last ten years. If the ten years of operation show little to no long term debt, then the company has some kind of strong competitive advantage.

Warren Buffett's historic purchases indicate that on any given year, the company should have sufficient yearly net earnings to pay all long term within 3 or 4 year earnings period. (e.g. Coke + Moody's = 1yr)

Companies with enough earning power to pay long term debt in less than 3 or 4 years is a good candidate in our search for long term competitive advantage.

BUT, these companies are targets for leveraged buy outs, which saddles the business with long term debt.

If all else indicates the company has a moat, but it has ton of debt, a leveraged buyout may have created the debt. In these cases the company's bonds offer the better bet, in that the company’s earnings power is focused on paying off the debt and not growth.

Important: little or no long term debt often means a Good Long Term Bet


Milestone Scientific Long-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Milestone Scientific's Long-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Milestone Scientific (Milestone Scientific) Business Description

Traded in Other Exchanges
N/A
Address
425 Eagle Rock Avenue, Roseland, NJ, USA, 07068
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Executives
Peter J Milligan officer: President 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Neal I Goldman director 170 SOUTHPORT DRIVE, MORRISVILLE NC 27560
Leslie Bernhard director C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019
Benedetta I Casamento director 200 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Leonard Osser director, 10 percent owner, officer: CEO
Leonard M Schiller director
Scott L. Kahn officer: Chief Financial Officer 425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068
Giandomenico Trombetta director, 10 percent owner CORSO VENEZIA 44, MILAN L6 20121
Joseph D'agostino officer: CFO & COO C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Jan Adriaan Haverhals officer: President 110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044
Brent W Johnston officer: President C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039
Michael Mcgeehan director C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039
Edward J. Zelnick director C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Daniel S Goldberger officer: President and CEO 24 CARPENTER ROAD, CHESTER NY 10918
Bp4 S.r.l. director, 10 percent owner, officer: See Remarks CORSO VENEZIA 44, MILAN L6 20121

Milestone Scientific (Milestone Scientific) Headlines